A new approach to drug design can deliver medicine directly to the gut in mice at significantly lower doses than current ...

Scientists found a compound that appears to counter common mutations behind POLG-related diseases, rare conditions that harm ...

A large trial showed that the weight-loss drug could reduce liver inflammation and scarring caused by the common condition.

The diabetes and weight loss drug semaglutide reversed liver scarring and inflammation. It’s among several drugs in the works for the condition MASH.

A late-stage clinical study showed that this weight loss drug helped 2 out of 3 people with the life-threatening liver ...

The FDA has approved the Janus kinase inhibitor upadacitinib for the treatment of giant cell arteritis in adults, the first ...

smarter treatment plans, and hope for countless families facing a hidden threat. Thanks to innovative research and powerful collaborations, heart disease may no longer have the upper hand.

Jason Hawkes, MD, MS, provided an in-depth look at the potential role of dupilumab (Dupixent; Sanofi and Regeneron ...

According to the results of the early study, published simultaneously in the New England Journal of Medicine, 92% of patients ...

Emma Dimery joined the clinical trial after running out of treatment options. For two years, she's been cancer free.

A panelist discusses how the treatment landscape for chronic graft-vs-host disease (cGVHD) has evolved significantly in ...

Without proper treatment, malaria can quickly become dangerous, even fatal. According to Centers for Disease Control and Prevention, malaria is a life-threatening disease caused by Plasmodium ...